F/M Investments’s Pfizer PFE Stock Holding History

F/M Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.14M	Sell	76,170 -220,786	-74%	-$5.88M	0.14%	103
2025 Q4	$7.39M	Buy	296,956 +184,420	+164%	+$4.65M	0.28%	90
2025 Q3	$2.87M	Sell	112,536 -3,953	-3%	-$97.6K	0.11%	194
2025 Q2	$2.82M	Buy	116,489 +6,472	+6%	+$151K	0.1%	196
2025 Q1	$2.79M	Buy	110,017 +15,966	+17%	+$418K	0.11%	187
2024 Q4	$2.5M	Buy	94,051 +12,895	+16%	+$350K	0.09%	200
2024 Q3	$2.34M	Sell	81,156 -6,743	-8%	-$197K	0.07%	205
2024 Q2	$2.46M	Buy	+87,899	New	+$2.42M	0.09%	197
2022 Q2	–	Sell	-62,684	Closed	-$3.25M	–	86
2022 Q1	$3.25M	Sell	62,684 -107	-0.2%	-$5.55K	2.62%	10
2021 Q4	$3.71M	Buy	62,791 +58,051	+1,225%	+$2.88M	2.71%	10
2021 Q3	$204K	Buy	+4,740	New	+$210K	0.15%	77

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

F/M Investments's PFE Position: Q1 2026 in Review

F/M Investments reduced its Pfizer (PFE) stake by 74% in Q1 2026, selling an estimated $5.88M and leaving 76,170 shares worth $2.14M. The position accounts for 0.14% of the portfolio, ranked #103.

F/M Investments first reported a position in PFE in Q3 2021 and has held it in 11 quarters since. The position peaked at $7.39M in Q4 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

F/M Investments held 76,170 shares of Pfizer worth $2.14M as of Q1 2026.
F/M Investments sold 220,786 Pfizer shares in Q1 2026, an estimated $5.88M.
Pfizer made up 0.14% of F/M Investments's portfolio in Q1 2026, its #103 holding.
F/M Investments first reported a position in Pfizer in Q3 2021 and has held it in 11 quarters since.
F/M Investments's Pfizer position peaked at $7.39M in Q4 2025.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.